Matt Bottomley analyst

Currently out of the existing stock ratings of Matt Bottomley, 14 are a HOLD (36.84%), 8 are a BUY (21.05%), 16 are a SELL (42.11%).

Matt Bottomley

Work Performance Price Targets & Ratings Chart

Analyst Matt Bottomley, carries an average stock price target met ratio of 61.9% that have a potential upside of 28.71% achieved within 183 days. Previously, Matt Bottomley worked at MIZUHO.

Matt Bottomley’s has documented 60 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on HEXO, Hexo Corp at 16-Jun-2023.

Wall Street Analyst Matt Bottomley

Analyst best performing recommendations are on APHA (APHRIA).
The best stock recommendation documented was for CGC (CANOPY GROWTH CORP) at 2/9/2021. The price target of $320 was fulfilled within 23 days with a profit of $170.9 (34.81%) receiving and performance score of 15.14.

Average potential price target upside

ACB Aurora Cannabis APHA Aphria CGC Canopy Growth Corp CURLF Curaleaf Holdings HEXO Hexo Corp TLRY Tilray CRON Cronos Group AYRWF AYR Strategies GTBIF Green Thumb Industries CCHWF Columbia Care MMNFF Medmen Enterprises VRNOF Verano Holdings Corp

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 11-Dec-2024

$9

$4.78 (113.27%)

1 years 27 days ago
(11-Dec-2024)

0/1 (0%)

$4.66 (107.37%)

Hold

Since 27-Jun-2024

$3

1 years 6 months 11 days ago
(27-Jun-2024)

4/4 (100%)

$-10 (-76.92%)

544

Hold

Since 15-Jun-2023

$1.5

$-2.72 (-64.45%)

2 years 6 months 23 days ago
(15-Jun-2023)

0/1 (0%)

$-3.82 (-71.80%)

Hold

Since 21-Sep-2022

$2

$-2.22 (-52.61%)

$3

3 years 10 days ago
(28-Dec-2022)

1/2 (50%)

$-6.47 (-76.39%)

531

Hold

3 years 7 months 22 days ago
(16-May-2022)

4/7 (57.14%)

$6.37 (31.42%)

9

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Matt Bottomley?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?